http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0555036-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-78
filingDate 1993-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1993-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0555036-A3
titleOfInvention Antitumor compositions and methods of treatment
abstract This invention provides the use of N-[[(3,4-dichlorophenyl)amino]carbonyl]-2,3-dihydrobenzofuran-5-sulfon amide, and pharmaceutically acceptable salts thereof, in the treatment of susceptible neoplasms in mammals. This invention further provides the novel aforementioned compound and its pharmaceutical formulations.
priorityDate 1992-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3102121-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0467613-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0291269-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0222475-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0166615-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3102115-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5169860-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129214490
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129219689
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID521197
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14815965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128035559
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14815963
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128589487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129222433
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19783515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53690418
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129693099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127763192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19783513
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8150
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128852002
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129496189
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7812
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136164596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129843355
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129873341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129069105
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10899619
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21708716
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128256876
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136059536
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128741603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53813613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127886212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19783521

Total number of triples: 58.